Content

Info

Links

Welcome to the CJU website » LOG IN
online search

Results for - "Moul W. Judd"    Showing 12 Results by Author

  1. Prostate cancer and testosterone: what does the prostate cancer surgeon need to know?
    Moul W. Judd;
    The Canadian Journal of Urology
    Aug 2024 (Volume 31, Issue 4, Pages 11941 - 11942)
    COMMENTARY
    PMID: 39217517
    Abstract  |  PDF (31.38 KB) Free
  1. Clinical utility of multiple secondary combined tests in prostate cancer screening
    Dudinec V. John, Wang M. Sabrina, Kotamarti Srinath, Morris E. Kostantinos, Polascik J. Thomas, Moul W. Judd;
    The Canadian Journal of Urology
    Jun 2023 (Volume 30, Issue 3, Pages 11538 - 11544)
    PMID: 37344464
    Abstract  |  PDF (255.43 KB) Free
  1. How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary care
    Moul W. Judd, Sant R. Grannum;
    The Canadian Journal of Urology
    Aug 2022 (Volume 29, Issue 4, Pages 11224 - 11230)
    PMID: 35969726
    Abstract  |  PDF (286.27 KB) Free
  1. The long-running disparity in early detection and treatment of prostate cancer in African American men
    Moul W. Judd;
    The Canadian Journal of Urology
    Feb 2022 (Volume 29, Issue 1, Pages 11003 - 11004)
    PMID: 35150222
    Abstract  |  PDF (32.64 KB) Free
  1. Aggressive prostate cancer masquerading as acute prostatitis
    Morris E. Kostantinos, Grimberg Dominic, Arcot Rohith, Moul W. Judd;
    The Canadian Journal of Urology
    Aug 2021 (Volume 28, Issue 4, Pages 10799 - 10801)
    PMID: 34378519
    Abstract  |  PDF (210.66 KB) Purchase
  1. The type of ADT may matter for testosterone recovery
    Moul W. Judd;
    The Canadian Journal of Urology
    Aug 2021 (Volume 28, Issue 4, Pages 10743 - 10743)
    PMID: 34378508
    Abstract  |  PDF (31.41 KB) Free
  1. Commentary V28I03
    Moul W. Judd;
    The Canadian Journal of Urology
    Jun 2021 (Volume 28, Issue 3, Pages 10668 - 10668)
    PMID: 34129458
    Abstract  |  PDF (33.82 KB) Free
  1. Secondary screening tests for prostate cancer: is more information better? Which test is best?
    Moul W. Judd;
    The Canadian Journal of Urology
    Feb 2020 (Volume 27, Issue 1, Pages 10086 - 10086)
    PMID: 32065863
    Abstract  |  PDF (34.09 KB) Free
  1. How I do it: Apalutamide use in non-metastatic castrate resistant prostate cancer
    Moul W. Judd;
    The Canadian Journal of Urology
    Jun 2019 (Volume 26, Issue 3, Pages 9782 - 9786)
    HOWIDOIT
    PMID: 31180310
    Abstract  |  PDF (52.17 KB) Free
  1. Over half of contemporary clinical Gleason 8 on prostate biopsy are downgraded at radical prostatectomy
    Qi Robert, Foo Wen-chi, Ferrandino N. Michael, Davis G. Leah, Sekar Sitharthan, Longo A. Thomas, Jibara Ghalib, Han Tracy, Gokhan Ilhan, Moul W. Judd;
    The Canadian Journal of Urology
    Oct 2017 (Volume 24, Issue 5, Pages 8982 - 8989)
    PMID: 28971784
    Abstract  |  PDF (70.02 KB) Purchase
  1. Low-risk prostate cancer patient: active treatment
    Moul W. Judd, Saad Fred;
    The Canadian Journal of Urology
    Jun 2005 (Volume 12, Pages 25 - 27)
    Abstract  |  PDF (62.53 KB) Purchase
  1. Utility of LHRH antagonists for advanced prostate cancer
    Moul W. Judd;
    The Canadian Journal of Urology
    Apr 2014 (Volume 21, Pages 22 - 27)
    PMID: 24775720
    Abstract  |  PDF (680.38 KB) Free